Taipei, Taiwan

Ya-Ying Li

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Golden Biotechnology Corporation. Active years: 2008.


% Patents Active = 100.0



Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Ya-Ying Li

Introduction

Ya-Ying Li is a notable inventor based in Taipei Hsien, Taiwan. With one patent to his name, his work focuses on innovative compounds derived from natural sources that hold potential for various medical applications. This article explores his latest patent achievements, career highlights, and collaborative efforts in the field of biotechnology.

Latest Patents

Ya-Ying Li's patent covers a novel compound extracted and purified from Antrodia camphorate, specifically identified as 4-hydroxy-2,3-dimethoxy-6-methyl-5(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone. This groundbreaking compound has never been previously discovered in Antrodia camphorate. It demonstrates significant potential in tumor growth inhibition, particularly in cancers such as breast, hepatic, and prostate cancer. The invention can further be utilized as a pharmaceutical composition to inhibit tumor growth or in the prevention of heart and blood vessel disease, providing health benefits through its antioxidant properties.

Career Highlights

Ya-Ying Li is associated with Golden Biotechnology Corporation, where he contributes his expertise in biotechnology and innovation. His work at the company signifies a commitment to advancing research and development in the field of medicinal compounds. His extensive knowledge and experience facilitate exploration into new pharmaceuticals that could transform cancer treatment and support overall health.

Collaborations

In his professional journey, Ya-Ying Li collaborates with esteemed colleagues such as Sheng-Yun Liu and Wu-Che Wen. These partnerships show the dynamic teamwork and exchange of ideas within Golden Biotechnology Corporation, enhancing the overall potency of their research initiatives.

Conclusion

Ya-Ying Li’s innovative contributions to biotechnology, particularly in developing solutions for cancer and health-related issues, underscore the importance of research in discovering new therapeutic options. His patent reflects both his ingenuity and dedication to improving health outcomes, laying a foundation for future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…